Bio-Techne (TECH) Assets Average (2010 - 2026)
Bio-Techne (TECH) posted quarterly Assets Average of $2.5 billion for Q1 2026, down 4.54% year-over-year from $2.7 billion in Q1 2025, and little changed quarter-over-quarter from $2.5 billion in Q4 2025.
Analysis
Bio-Techne (TECH) Assets Average (2010 - 2026) Analysis & Trends
Bio-Techne's Assets Average history runs 17 years deep, the most recent figure standing at $2.5 billion for Q1 2026.
- In Q1 2026, Assets Average fell 4.54% year-over-year to $2.5 billion; the TTM figure through Mar 2026 stood at $2.5 billion (down 4.54% YoY), while the FY2025 annual figure was $2.6 billion, down 1.51% from the prior year.
- Assets Average for Q1 2026 stood at $2.5 billion, roughly flat from $2.5 billion in the prior quarter.
- The five-year high for Assets Average was $2.7 billion in Q4 2023, with the low at $2.3 billion in Q2 2022.
- The 5-year median for Assets Average is $2.6 billion (2025), against an average of $2.6 billion.
- The sharpest annual moves came in 2023 and 2025: Assets Average grew 16.38% in 2023, then retreated 6.61% in 2025.
- Bio-Techne's Assets Average stood at $2.4 billion in 2022, then advanced by 16.38% to $2.7 billion in 2023, then retreated by 1.45% to $2.7 billion in 2024, then decreased by 6.61% to $2.5 billion in 2025, then rose by 0.48% to $2.5 billion in 2026.
- Business Quant data shows TECH's Assets Average at $2.5 billion in Q1 2026, $2.5 billion in Q4 2025, and $2.5 billion in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 63.55 Bn | 58.37 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | 11.22 Bn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | 3.29 Bn |
| 6 | BeOne Medicines | 39.98 Bn | 34.89 Bn | 1.53 Bn | 8.86 Bn |
| 7 | Alnylam Pharmaceuticals | 35.32 Bn | 32.01 Bn | 992.69 Mn | 5.34 Bn |
| 8 | Royalty Pharma | 28.42 Bn | 27.59 Bn | - | 19.82 Bn |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Bio-Techne | 11.30 Bn | 11.03 Bn | 211.39 Mn | 2.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.57 Bn |
| Mar 31, 2026 | 2.54 Bn |
| Dec 31, 2025 | 2.52 Bn |
| Sep 30, 2025 | 2.54 Bn |
| Jun 30, 2025 | 2.60 Bn |
| Mar 31, 2025 | 2.66 Bn |
| Dec 31, 2024 | 2.70 Bn |
| Sep 30, 2024 | 2.72 Bn |
| Jun 30, 2024 | 2.71 Bn |
| Mar 31, 2024 | 2.73 Bn |
| Dec 31, 2023 | 2.74 Bn |
| Sep 30, 2023 | 2.70 Bn |
| Jun 30, 2023 | 2.62 Bn |
| Mar 31, 2023 | 2.48 Bn |
| Dec 31, 2022 | 2.36 Bn |
| Sep 30, 2022 | 2.32 Bn |
| Jun 30, 2022 | 2.30 Bn |
| Mar 31, 2022 | 2.30 Bn |
| Dec 31, 2021 | 2.29 Bn |
| Sep 30, 2021 | 2.27 Bn |